Wewoka Animal Hospital
Letter data
- Company
- Wewoka Animal Hospital
- Recipient
- Dr. Rory G. Stricklin | Wewoka Animal Hospital | Robie Watters | 12821 Ns 3650 | Wewoka | , | OK | 74884 | United States
- Issue date
- 2021-06-24
- Posted date
- Not available
- FDA office
- Division of Human and Animal Food Operations West III
- Subject
- Not available
- Product
- Animal & Veterinary
- CMS ID
- 577595
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Wewoka Animal Hospital
MARCS-CMS 577595 —
June 24, 2021
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
UPS Overnight
Product:
Animal & Veterinary
Recipient:
Recipient Name
Dr. Rory G. Stricklin
Wewoka Animal Hospital
Robie Watters
12821 Ns 3650
Wewoka
,
OK
74884
United States
Issuing Office:
Division of Human and Animal Food Operations West III
United States
Secondary Issuing Offices
United States
Dear Dr. Rory G. Stricklin:
The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter (CMS #577595, dated June 3, 2019) issued following an inspection of your Wewonka Animal Hospital located at 12821 Ns 3650, Wewoka, Oklahoma 74884. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Jessica E. Havranek
Director, Compliance Branch
Human & Animal Food Operations, WD3
Content current as of:
12/15/2023
Regulated Product(s)
Animal & Veterinary